Summit DMD Data Intrigue But Longer-Term Results Awaited

 
• By Alexandra Shimmings

Early data for ezutromid in Duchenne muscular dystrophy product give some proof of concept as a broad treatment for the fatal genetic disease – more data are awaited as Summit steps up its pivotal trial plans.

Sunlight
Early Signs Of Efficacy For DMD Drug • Source: Shutterstock

More from R&D

More from Scrip